EXPLAINED: 5 | Rare Historical Photos

Gen X drugmaker is coughing up millions for Paris Olympics sponsorship to show Gen Z and millennials it's a cool place to work

Sanofi is hoping the exposure will help put the brand in front of prospective young talent which it has struggled to recruit.

Fortune · Jan 10, 2024

Insulin Now Available for $35 a Month for Many Americans

Insulin price caps from Eli Lilly, Novo Nordisk and Sanofi take effect this month.

Kiplinger · Jan 3, 2024

Insulin prices to drop after manufacturers cap costs

Good news for Americans with diabetes as Sanofi becomes the third major insulin manufacturer to cap costs at per month, reducing financial strain and i...

Top News · Jan 2, 2024

3 Pharma Stocks on the Rise - Buy Now

The pharmaceutical industry is well-positioned for long-term growth thanks to rising investments in drug development and technological advancements. Thus, it would be prudent to buy pharma stocks, Sanofi (SNY), Johnson & Johnson (JNJ) and AstraZeneca PLC (AZN). Read on.

StockNews.com · Oct 26, 2023

A new RSV shot could help protect babies this winter — if they can get it in time

Hospitals were overwhelmed last winter by a surge in pediatric cases of RSV. Now a new monoclonal antibody shot could help, but price and supply issues are causing delays in getting it to infants.

WEKU · Oct 25, 2023

A new RSV shot for infants is in short supply

A new shot for infants against RSV is in short supply, and U.S. health officials are telling doctors they should prioritize giving the drug to babies at the highest risk of severe disease

The Independent UK · Oct 24, 2023

3 Pharma Stocks to Buy Now for a Dose of Profit

The pharmaceutical sector is expanding due to advanced technologies such as AI and new drug discoveries. Hence, quality pharma stocks GoodRx Holdings (GDRX), Merck & Co. (MRK), and Sanofi (SNY) might be profitable investments right now. Read on.

StockNews.com · Sep 6, 2023

3 Pharma Stocks Investors Are Chasing for Value

With the advent of advanced medications and the increasing need for personalized treatments, the pharmaceutical industry looks well-poised for long-term growth. Therefore, it could be worth looking into three fundamentally sound pharma stocks, Pfizer (PFE), Sanofi (SNY), and GSK plc (GSK), that are offering significant value. Read more….

StockNews.com · Aug 8, 2023

New drug to protect babies and toddlers from RSV gets FDA approval ahead of cold season

U.S. officials have approved a new long-acting drug to protect babies and toddlers against a respiratory virus that causes thousands of hospitalizations each year

The Independent UK · Jul 17, 2023

Revealed: pharma giants pour millions of pounds into NHS to boost drug sales

Observer investigation raises concerns about the influence of drugs companies in shaping patient care in services that use their products

The Guardian - UK · Jul 8, 2023